The American Journal of Surgical Pathology · 2005 · 13 citations · 44 references
Although a larger number of cases should be studied to validate these results, these data provide evidence that differences in signaling through the death-receptor apoptosis pathway mediated by FADD may be responsible for the varying biologic behaviors of CD30-positive lymphoproliferative disorders involving the skin.
44
Safety and antitumor activity of recombinant soluble Apo2 ligand
Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text
Marcel W. Bekkenk, Françoise A. M. J. Geelen, Pieter C. van Voorst Vader et al. · Blood · 2000 · 777 citations
ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology
Daniel Benharroch, Zarouhie Meguerian-Bedoyan, Laurence Lamant et al. · Blood · 1998 · 525 citations · Full text